Literature DB >> 33623582

The epidemiological and clinical profile of COVID-19 in children: Moroccan experience of the Cheikh Khalifa University Center.

Nabila Chekhlabi1,2,3, Chafik El Kettani4, Amal Haoudar4, Abdelkrim Bahlaoui5, Mohamed Mahi6,7, Said Ettair1,7, Nezha Dini1,7.   

Abstract

INTRODUCTION: COVID-19 is an infectious disease caused by a new coronavirus. The first cases were identified in Wuhan. It rapidly spread causing a pandemic worldwide. The incidence and severity of this disease are likely to be different in children compared with adults. Few publications of COVID-19 in children have been published. Our Moroccan paediatric series is among the first studies on this disease in Africa.
METHODS: We included all children with COVID-19 who were admitted and treated at the hospital from March 25 to April 26, 2020. We have collected information, including demographic data, symptoms, imaging data, laboratory results, treatments and clinical progress from patients with COVID-19.
RESULTS: Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Morocco, a total of 145 COVID-19 confirmed cases have been reported in the Cheikh Khalifa's Hospital. Among this cases, 15 children were registered. The median age of patients was 13 years. There were 7 boys and 8 girls. Five children are asymptomatic, 8 have mild symptoms and 2 have a moderate respiratory difficulty. The RT-PCR test results were positive in all patients. Radiologically, we found in 2 cases, multiple nodules with ground-glass opacities on the chest scan. The treatment was based on the combination of hydroxychloroquine and azithromycin. Evolution under treatment was good for all patients.
CONCLUSION: This study describes the profile of COVID-19 in child in a Moroccan hospital and confirms that the severity of illness in children with COVID-19 to be far less than adults. © Nabila Chekhlabi et al.

Entities:  

Keywords:  COVID-19; children; coronavirus

Mesh:

Substances:

Year:  2020        PMID: 33623582      PMCID: PMC7875728          DOI: 10.11604/pamj.supp.2020.35.2.23571

Source DB:  PubMed          Journal:  Pan Afr Med J


  14 in total

1.  Why is COVID-19 so mild in children?

Authors:  Petter Brodin
Journal:  Acta Paediatr       Date:  2020-04-15       Impact factor: 2.299

2.  COVID-19 in Children: Initial Characterization of the Pediatric Disease.

Authors:  Andrea T Cruz; Steven L Zeichner
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

3.  Chloroquine for the 2019 novel coronavirus SARS-CoV-2.

Authors:  Philippe Colson; Jean-Marc Rolain; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-02-15       Impact factor: 5.283

4.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

5.  Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State.

Authors:  Chikara Ogimi; Janet A Englund; Miranda C Bradford; Xuan Qin; Michael Boeckh; Alpana Waghmare
Journal:  J Pediatric Infect Dis Soc       Date:  2019-03-28       Impact factor: 3.164

6.  Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

7.  Chest computed tomography in children with COVID-19 respiratory infection.

Authors:  Wei Li; Huaqian Cui; Kunwei Li; Yijie Fang; Shaolin Li
Journal:  Pediatr Radiol       Date:  2020-03-11

8.  Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Authors:  Joshua Geleris; Yifei Sun; Jonathan Platt; Jason Zucker; Matthew Baldwin; George Hripcsak; Angelena Labella; Daniel K Manson; Christine Kubin; R Graham Barr; Magdalena E Sobieszczyk; Neil W Schluger
Journal:  N Engl J Med       Date:  2020-05-07       Impact factor: 91.245

9.  A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features.

Authors:  Cai Jiehao; Xu Jin; Lin Daojiong; Yang Zhi; Xu Lei; Qu Zhenghai; Zhang Yuehua; Zhang Hua; Jia Ran; Liu Pengcheng; Wang Xiangshi; Ge Yanling; Xia Aimei; Tian He; Chang Hailing; Wang Chuning; Li Jingjing; Wang Jianshe; Zeng Mei
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

10.  Does pandemic justify the use of hydroxychloroquine for treatment and prevention of COVID-19 in India?

Authors:  Jaya Prasad Tripathy
Journal:  J Med Virol       Date:  2020-06-03       Impact factor: 20.693

View more
  2 in total

1.  Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.

Authors:  Testimony Jesupamilerin Olumade; Leonard Ighodalo Uzairue
Journal:  J Med Virol       Date:  2021-02-12       Impact factor: 20.693

2.  Epidemiology, Clinical Profile, Intensive Care Needs and Outcome in Children with SARS-CoV-2 Infection Admitted to a Tertiary Hospital During the First and Second Waves of the COVID-19 Pandemic in India.

Authors:  Vishwa C R; Raman Sharma; Muralidharan Jayashree; Karthi Nallasamy; Arun Bansal; Suresh Kumar Angurana; Joseph L Mathew; Naveen Sankhyan; Sourabh Dutta; Sanjay Verma; Rakesh Kumar; Mahesh Devnanai; Pankaj C Vaidya; Ram Samujh; Mini P Singh; Kapil Goyal; P V M Lakshmi; Akshay K Saxena
Journal:  Indian J Pediatr       Date:  2022-08-03       Impact factor: 5.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.